Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 8/20 | 0.48 |
| ▸ | MGLL | Q99685 | 2/20 | 0.40 |
| ▸ | PARP1 | P09874 | 5/20 | 0.39 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.39 |
| ▸ | TNKS | O95271 | 4/20 | 0.37 |
| ▸ | TNKS2 | Q9H2K2 | 4/20 | 0.37 |
| ▸ | SGMS2 | Q8NHU3 | 3/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4493367 | 0.90 | CETP (0.43) | CETPPARP1 | |
| SCHEMBL4493136 | 0.82 | CETP (0.51) | CETPSGMS2TRPV1SGMS1 | |
| SCHEMBL4499632 | 0.81 | CETP (0.51) | CETPSGMS2SGMS1 | |
| SCHEMBL4511810 | 0.81 | CETP (0.55) | CETPSGMS2SGMS1 | |
| SCHEMBL4506070 | 0.80 | CETP (0.53) | CETPSGMS2SGMS1 | |
| SCHEMBL4506131 | 0.79 | CETP (0.49) | CETPNOTUM | |
| SCHEMBL1587751 | 0.79 | CETP (0.53) | CETPNOTUM | |
| SCHEMBL1587774 | 0.75 | CETP (0.57) | CETPNOTUM | |
| SCHEMBL4490319 | 0.74 | CETP (0.45) | CETPSGMS2SGMS1 | |
| SCHEMBL20768071 | 0.74 | CETP (0.51) | CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023729-A1 | Trisubstituted amine compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20090023729-A1 | Trisubstituted amine compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20090023729-A1 | Trisubstituted amine compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023729-A1 | Trisubstituted amine compound | CETP, MTTP, APOB | CETP 1/4885MGLL 30/4885PARP1 3573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.